TGFBR2 and prostate cancer: CAFs isolated from Tgfβr2 knockout mice have also been shown to increase tumor growth and proliferation in LNCaP human prostate cancer recombinants in a Wnt3a-dependent manner [133], indicating TGFβR2-deficient CAFs may contribute to prostate cancer growth in patients.